Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Supernus Pharma Insider Sells $5.4 Million as Stock Surges 53% in a Year
Padmanabh P. Bhatt, Sr. VP of IP and CSO at Supernus Pharmaceuticals (SUPN 2.51%), reported the direct sale of 107,250 shares of Common Stock over March 16–18, 2026, via open-market transactions, for a transaction value of approximately $5.4…
ANI Pharma Insider Sells 4,772 Shares as Revenue Hits $883 Million in 2025
Thomas Rowland, an executive at ANI Pharmaceuticals (ANIP 1.78%), reported the sale of 4,772 shares of common stock in an open-market transaction on March 11, 2026, according to a SEC Form 4 filing. MetricValueShares sold (direct)4,772Transaction…
Xenon Pharma Stock Up 55% as Insider Sells $78K in Shares. Here's What Investors Should Know
Christopher John Kenney, the chief medical officer of Xenon Pharmaceuticals Inc. (XENE 1.89%), reported a direct sale of 1,410 common shares for a total of approximately $78,000 on March 13, 2026, as disclosed in this SEC Form 4 filing.
Ligand Pharma CFO Sells $688K in Stock as Shares Surge 80% This Past Year. Here's What to Know
On March 11, 2026, Ligand Pharmaceuticals (LGND 3.94%) Chief Financial Officer Octavio Espinoza reported the sale of 3,057 shares of common stock for a transaction value of approximately $688,000, according to a SEC Form 4 filing. MetricValueShares…
UK 'weeks away' from medicine shortages if Iran war continues, experts say
Britain is “a few weeks away” from medicine shortages ranging from painkillers to cancer treatment if the Iran war continues, according to experts, while drug prices could also rise. The conflict has disrupted the supply of a myriad…
Spyglass Pharma (NASDAQ:SGP) Cut to 'Sell' at Wall Street Zen
Spyglass Pharma (NASDAQ:SGP - Get Free Report) was downgraded by research analysts at Wall Street Zen from a 'hold' rating to a 'sell' rating in a research report issued on Saturday. A number of other analysts have also issued reports on the…
Wedge Capital Management L L P NC Lowers Stock Position in Royalty Pharma PLC $RPRX
Wedge Capital Management L L P NC decreased its holdings in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 12.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The…
UK just 'a few weeks' from medicine shortages
Medicine shortages could be looming, experts have warned Britain is teetering on the brink of full-blown medicine shortages, with everything from painkillers to critical cancer treatments likely to be in short supply if the war with Iran drags on…
Wealth Enhancement Advisory Services LLC Buys 165,451 Shares of Royalty Pharma PLC $RPRX
Wealth Enhancement Advisory Services LLC grew its position in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 701.2% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 189,046 shares of…
Ireland: How will energy crisis hit the economy?
Economics and business editor, BBC News NI Ireland's government this week moved to support people who are starting to feel the economic hit from the Iran war. Taxes on petrol and diesel were cut and there was an extra €150 benefit for around…
DSP Healthcare: Playing It Safe
The US-Iran conflict has impacted every segment of the equity market in the last three weeks including the healthcare sector, BSE Healthcare and Nifty Pharma nonetheless. Compared to 11 per cent decline year-to-date in Nifty 50, BSE Healthcare has…
Cramer's game plan: Oil shock is driving this sell-off and tech won't bottom until it ends
Jim Cramer says the market sell-off is driven by rising oil tied to the Iran war, with tech stocks taking a huge hit. His game plan highlights key earnings and economic data next week that could determine whether stocks stabilize or fall further.
SOUTH CAROLINA AG WILSON: Fentanyl is a national security threat - follow the Chinese money
Every day, families across this country are losing loved ones to fentanyl. This is not just a public safety crisis. It is not just a public health emergency. It is something far more dangerous. It is a national security threat. As attorneys…
Gym Bros Are Pushing Mystery Muscle Drugs Doctors Barely Recognize, Study Warns
Doctors are only now starting to catch up on the weird, rapidly growing, and wildly unregulated world of underground bodybuilding supplements. Even with surging media attention on the rise of dubious performance-enhancing drugs, like peptides, some…
PPH ETF: Drug Pricing Policy and Eli Lilly Concentration Are the Two Risks to Watch in 2026
VanEck Pharmaceutical ETF (PPH) is 17.91% concentrated in Eli Lilly (LLY), which has fallen 16% year-to-date as generic GLP-1 competition and patent expirations in emerging markets threaten pricing power, while Novartis (NVS) holds 11.23% and Merck…
Receive a Daily briefing on Pharma Industry News
Get Started